Ignite Creation Date:
2025-12-25 @ 4:56 AM
Ignite Modification Date:
2026-05-07 @ 7:47 PM
Study NCT ID:
NCT00042718
Status:
COMPLETED
Last Update Posted:
2010-04-28
First Post:
2002-08-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of the Effectiveness and Safety of High Dose, Short-course Levofloxacin in the Treatment of Acute Bacterial Exacerbation (Worsening) of Chronic Bronchitis.
Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CR002650
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |